🌟 Important Update on Medicine Shortages 🌟
🚨 The EMA and HMA are addressing shortages of essential diabetes and weight management drugs like Ozempic, Saxenda, Trulicity, and Victoza. 🚨
🌍💊 Importance of GLP-1 Receptor Agonists: These medicines are crucial for managing diabetes and weight in people with obesity or related health issues.
📈 Why the Shortages? Since 2022, high demand and manufacturing issues have led to shortages, worsened by misuse for cosmetic weight loss and the risk of fake products. 🚫💊
🔍 Here's what they're doing to help:
➡️ Collaborating: Bringing together industry, regulators, healthcare professionals, and the public.
➡️ Controlling Distribution: Working with manufacturers to ensure fair distribution.
➡️ Prioritising Patients: Making sure those who need these medicines the most get them.
➡️ Boosting Production: Increasing manufacturing capacity.
➡️ Educating: Raising awareness about the proper use of these drugs.
A big workshop is scheduled for July 1, 2024, to discuss more solutions.
✅ A big workshop is scheduled for July 1, 2024, to discuss more solutions. 🤝
👥 For the public:
➡️ Use these medicines only under medical supervision. ⚠️
➡️ Avoid buying from unverified online sources. ❌
➡️ Talk to your doctor if your medicine is unavailable. 💬
🔗 More info: EMA Official Site
hashtag
#Healthcare hashtag
#Pharmaceuticals hashtag
#GLP1 hashtag
#DiabetesCare hashtag
#WeightManagement hashtag
#PublicHealth hashtag
#MedicineShortages hashtag
#PatientCare hashtag
#DrugSafety hashtag
#MedicalUpdates hashtag
#RegulatoryActions hashtag
#HealthAwareness hashtag
#DiabetesManagement hashtag
#WeightLoss hashtag
#ObesityTreatment
@EMA_News @HMA_Health @DiabetesUK @DiabetesAssoc @HealthEU @ObesitySociety @PharmaNews @Healthline @WHO @UNHealth
We have just published recommendation to help tackle shortages of #GLP1 receptor agonists across the EU 💊🤲 looking out for the patients who need them most.
▶ https://lnkd.in/eW9yvkrN